Spin-offs
The IOCB started the process of the commercialization of the IP via spin-offs in 2009 through the creation of the first spin-off company, Mendel Therapeutics, s.r.o. For more information, please visit www.mendel-therapeutics.com
The IOCB is also a partner in the project of OKAPI Sciences company based in Belgium. For more information please visit http://www.okapi-sciences.com/
quick contact
Flemingovo n. 2, 16610
Prague, Czech Republic
tel.: +420 220 612 258
email: info@iocb-tto.cz